Skip to main content
Top
Published in: Journal of Clinical Immunology 1/2012

01-02-2012

Endothelial Cell Function in Patients with Hereditary Angioedema: Elevated Soluble E-selectin Level During Inter-attack Periods

Authors: Judit Czúcz, Gyula Schaffer, Dorottya Csuka, Szilvia Walentin, Jan Kunde, Zoltán Prohászka, Henriette Farkas, László Cervenak

Published in: Journal of Clinical Immunology | Issue 1/2012

Login to get access

Abstract

Background

The bradykinin pathway in the pathomechanism of hereditary angioedema due to C1-inhibitor deficiency (henceforward “hereditary angioedema”) has been thoroughly studied; however, much less is known about endothelial cell function. Enhanced endothelial cell permeability is obvious during edematous attacks, but not during inter-attack periods. Our knowledge about other endothelial characteristics is even more incomplete.

Objective

Therefore the aim of this study was to characterize endothelial cell function in hereditary angioedema patients during symptom-free, inter-attack periods.

Methods

We measured the serum levels of soluble E-selectin, endothelin-1, and von Willebrand factor along with collagen-binding activity in 49 hereditary angioedema patients and in 50 healthy controls.

Results

Endothelin-1 and von Willebrand factor level, as well as its collagen-binding activity, were similar in hereditary angioedema patients and in controls; however, we found elevated soluble E-selectin levels in the patients. Interestingly, soluble E-selectin concentration did not correlate with any of the inflammatory markers or smoking, and it is not the consequence of the known E-selectin/C1-inhibitor interaction (an analytical phenomenon). In a multiple logistic regression model, the difference in soluble E-selectin between hereditary angioedema patients and controls remained highly significant when adjusted for age, gender, smoking, C-reactive protein, and AB0 blood groups.

Conclusion

These results demonstrate that in hereditary angioedema, the majority of endothelial functions are normal during inter-attack periods; however, soluble E-selectin levels are elevated. The higher soluble E-selectin plasma concentration is unlikely to result from inflammation; rather, it reflects enhanced shedding mechanisms.
Literature
1.
go back to reference Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med. 2001;161:2417–29.PubMedCrossRef Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med. 2001;161:2417–29.PubMedCrossRef
2.
go back to reference Agostoni A, Aygören-Pürsün E, Binkley KE, Blanch A, Bork K, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and Beyond. J Allergy Clin Immunol. 2004;114:S51–S131. doi:10.1016/j.jaci.2004.06.047.PubMedCrossRef Agostoni A, Aygören-Pürsün E, Binkley KE, Blanch A, Bork K, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and Beyond. J Allergy Clin Immunol. 2004;114:S51–S131. doi:10.​1016/​j.​jaci.​2004.​06.​047.PubMedCrossRef
3.
go back to reference Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore). 1992;71:206–15. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore). 1992;71:206–15.
11.
go back to reference Sumpio BE, Riley JT, Dardik A. Cells in focus: endothelial cell. Int J Biochem Cell Biol. 2002;34:1508–12.PubMedCrossRef Sumpio BE, Riley JT, Dardik A. Cells in focus: endothelial cell. Int J Biochem Cell Biol. 2002;34:1508–12.PubMedCrossRef
13.
go back to reference Roldán V, Marín F, Lip GYH, Blann AD. Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature. Thromb Haemost. 2003;90:1007–20. doi:10.1267/THRO03061007.PubMed Roldán V, Marín F, Lip GYH, Blann AD. Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature. Thromb Haemost. 2003;90:1007–20. doi:10.​1267/​THRO03061007.PubMed
14.
go back to reference Pigott R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun. 1992;187:584–9.PubMedCrossRef Pigott R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun. 1992;187:584–9.PubMedCrossRef
16.
go back to reference Lip GY, Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res. 1997;34:255–65.PubMedCrossRef Lip GY, Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res. 1997;34:255–65.PubMedCrossRef
17.
go back to reference Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010;6:24. doi:10.1186/1710-1492-6-24.PubMedCrossRef Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010;6:24. doi:10.​1186/​1710-1492-6-24.PubMedCrossRef
18.
go back to reference Bowen T, Cicardi M, Bork K, Zuraw B, Frank M, et al. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol. 2008;100:S30–40.PubMedCrossRef Bowen T, Cicardi M, Bork K, Zuraw B, Frank M, et al. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol. 2008;100:S30–40.PubMedCrossRef
20.
go back to reference Thorand B, Baumert J, Döring A, Schneider A, Chambless L, et al. Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women. Results from the MONICA/KORA Augsburg Study. Thromb Haemost. 2006;95:134–41.PubMed Thorand B, Baumert J, Döring A, Schneider A, Chambless L, et al. Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women. Results from the MONICA/KORA Augsburg Study. Thromb Haemost. 2006;95:134–41.PubMed
21.
go back to reference Bermudez EA, Rifai N, Buring JE, Manson JE, Ridker PM. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol. 2002;89:1117–9.PubMedCrossRef Bermudez EA, Rifai N, Buring JE, Manson JE, Ridker PM. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol. 2002;89:1117–9.PubMedCrossRef
22.
go back to reference Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, et al. Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol. 2009;29:1958–67. doi:10.1161/ATVBAHA.109.192971.PubMedCrossRef Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, et al. Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol. 2009;29:1958–67. doi:10.​1161/​ATVBAHA.​109.​192971.PubMedCrossRef
23.
go back to reference Cai S, Davis AE. Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion. J Immunol. 2003;171:4786–91.PubMed Cai S, Davis AE. Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion. J Immunol. 2003;171:4786–91.PubMed
24.
go back to reference Cai S, Dole VS, Bergmeier W, Scafidi J, Feng H, et al. A direct role for C1 inhibitor in regulation of leukocyte adhesion. J Immunol. 2005;174:6462–6.PubMed Cai S, Dole VS, Bergmeier W, Scafidi J, Feng H, et al. A direct role for C1 inhibitor in regulation of leukocyte adhesion. J Immunol. 2005;174:6462–6.PubMed
25.
go back to reference Edgar JDM, Gabriel V, Gallimore JR, McMillan SA, Grant J. A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal infection. BMC Pediatr. 2010;10:22. doi:10.1186/1471-2431-10-22.PubMedCrossRef Edgar JDM, Gabriel V, Gallimore JR, McMillan SA, Grant J. A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal infection. BMC Pediatr. 2010;10:22. doi:10.​1186/​1471-2431-10-22.PubMedCrossRef
27.
go back to reference Nasuno A, Matsubara T, Hori T, Higuchi K, Imai S, et al. Levels of soluble E-selectin and ICAM-1 in the coronary circulation of patients with stable coronary artery disease: association with the severity of coronary atherosclerosis. Jpn Heart J. 2002;43:93–101.PubMedCrossRef Nasuno A, Matsubara T, Hori T, Higuchi K, Imai S, et al. Levels of soluble E-selectin and ICAM-1 in the coronary circulation of patients with stable coronary artery disease: association with the severity of coronary atherosclerosis. Jpn Heart J. 2002;43:93–101.PubMedCrossRef
29.
go back to reference Stancanelli B, Malatino LS, Cataliotti A, Bellanuova I, Mallamaci F, et al. Soluble e-selectin is an inverse and independent predictor of left ventricular wall thickness in end-stage renal disease patients. Nephron Clin Pract. 2010;114:c74–80. doi:10.1159/000252806.PubMedCrossRef Stancanelli B, Malatino LS, Cataliotti A, Bellanuova I, Mallamaci F, et al. Soluble e-selectin is an inverse and independent predictor of left ventricular wall thickness in end-stage renal disease patients. Nephron Clin Pract. 2010;114:c74–80. doi:10.​1159/​000252806.PubMedCrossRef
30.
go back to reference Hayashi S, Abe K, Matsuoka H, Goya S, Morishita H, et al. Increased level of soluble E-selectin in the serum from patients with idiopathic pulmonary fibrosis. Inflammation. 2004;28:1–5.PubMedCrossRef Hayashi S, Abe K, Matsuoka H, Goya S, Morishita H, et al. Increased level of soluble E-selectin in the serum from patients with idiopathic pulmonary fibrosis. Inflammation. 2004;28:1–5.PubMedCrossRef
34.
go back to reference Ruchaud-Sparagano MH, Walker TR, Rossi AG, Haslett C, Dransfield I. Soluble E-selectin acts in synergy with platelet-activating factor to activate neutrophil beta 2-integrins. Role of tyrosine kinases and Ca2+ mobilization. J Biol Chem. 2000;275:15758–64. doi:10.1074/jbc.M907390199.PubMedCrossRef Ruchaud-Sparagano MH, Walker TR, Rossi AG, Haslett C, Dransfield I. Soluble E-selectin acts in synergy with platelet-activating factor to activate neutrophil beta 2-integrins. Role of tyrosine kinases and Ca2+ mobilization. J Biol Chem. 2000;275:15758–64. doi:10.​1074/​jbc.​M907390199.PubMedCrossRef
36.
go back to reference Ulich TR, Howard SC, Remick DG, Yi ES, Collins T, et al. Intratracheal administration of endotoxin and cytokines: VIII. LPS induces E-selectin expression; anti-E-selectin and soluble E-selectin inhibit acute inflammation. Inflammation. 1994;18:389–98.PubMedCrossRef Ulich TR, Howard SC, Remick DG, Yi ES, Collins T, et al. Intratracheal administration of endotoxin and cytokines: VIII. LPS induces E-selectin expression; anti-E-selectin and soluble E-selectin inhibit acute inflammation. Inflammation. 1994;18:389–98.PubMedCrossRef
37.
go back to reference Sung BH, Kim SH, Yeo MG, Kim J-K, Song WK. Human soluble E-selectin immunoadhesin inhibits leukemic monocyte adhesion to endothelial cells. Cell Biochem Funct. 2007;25:585–9. doi:10.1002/cbf.1361.PubMedCrossRef Sung BH, Kim SH, Yeo MG, Kim J-K, Song WK. Human soluble E-selectin immunoadhesin inhibits leukemic monocyte adhesion to endothelial cells. Cell Biochem Funct. 2007;25:585–9. doi:10.​1002/​cbf.​1361.PubMedCrossRef
Metadata
Title
Endothelial Cell Function in Patients with Hereditary Angioedema: Elevated Soluble E-selectin Level During Inter-attack Periods
Authors
Judit Czúcz
Gyula Schaffer
Dorottya Csuka
Szilvia Walentin
Jan Kunde
Zoltán Prohászka
Henriette Farkas
László Cervenak
Publication date
01-02-2012
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 1/2012
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-011-9606-7

Other articles of this Issue 1/2012

Journal of Clinical Immunology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.